Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

The Bullish Case for Aurora Cannabis Is so Close Yet so Far Away

The long-term outlook for the cannabis market gives ACB stock an appealing bullish case, but that does nothing for investors in the near term.

The Reward of Buying Carnival Shares Isn’t Worth the Risk

Carnival is taking its first steps toward normalcy, and CCL stock may have calmer waters ahead. Still, remaining risks may curtail growth.

CureVac Stock Is Just Another Part of a Bigger Story

With its Covid-19 vaccine candidate, CureVac stock soared after its IPO in August. But as Operation Warp Speed wraps up, investors may wonder if there's anything else.

The 5 Best Cheap Stocks to Buy for Contrarian Investors

Investors are looking for value wherever they can find it. One of the tried-and-true ways to find cheap stocks to buy is to look for contrarian plays.

The Tech Wreck Is Just What Advanced Micro Devices Needed

Advanced Micro Devices is one of the best performing stocks of 2020. That's why investors should celebrate the dip in AMD stock price as a great buying opportunity.